Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02324036 · ClinicalTrials.gov registry record · Early Phase 1
The EMPATHy Toolkit: Helping Diabetes Patients Overcome Barriers to Medication Adherence
A Early Phase 1 study, sponsored by University of California, Irvine.
- Completed
- Registry status
- Early Phase 1
- Development phase
- 190
- Enrollment target
NCT02324036 is a Early Phase 1 study that has completed, run by University of California, Irvine. The registered enrollment target is 190 participants.
The verdict
NCT02324036, a Early Phase 1 study, has completed, sponsored by University of California, Irvine.
- COMPLETED
- Registry status
- Early Phase 1
- Development phase
- 190 participants
- Enrollment target
Study Summary
The proposed study is a pilot study to gather data on the effectiveness and feasibility of a software tool (EMPATHy) to help patients communicate effectively with doctors about problems they face with their medication regimens. EMPATHy will be incorporated into an existing clinic-based intervention called Coached Care, in which community health workers (CHWs, non-professional community members) work as a "Coach" to patients to help them improve engagement and communication during the medical visit.
Interventions
- BEHAVIORAL Coached Care
- DEVICE EMPATHy Toolkit
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 190 participants |
| Start Date | 2014-12 |
| Est. Completion | 2015-08 |
| Phase | Early Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02324036
The ClinicalTrials.gov registry entry for NCT02324036 describes a study currently listed as completed, categorized as Early Phase 1. The registered enrollment target is 190 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of California, Irvine, which has 368 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Coached Care is the first listed.
NCT02324036 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02324036 about?
NCT02324036 is a clinical study titled "The EMPATHy Toolkit: Helping Diabetes Patients Overcome Barriers to Medication Adherence". The proposed study is a pilot study to gather data on the effectiveness and feasibility of a software tool (EMPATHy) to help patients communicate effectively with doctors about problems they face with their medication regimens. EMPATHy will be incorporated into an existing clinic-based intervention ...
What is the current status of trial NCT02324036?
This trial is currently completed. It is a Early Phase 1 study. The enrollment target is 190 participants. The study started on 2014-12. Estimated completion is 2015-08.
What interventions are being tested in trial NCT02324036?
The interventions under investigation include: Coached Care (BEHAVIORAL), EMPATHy Toolkit (DEVICE).
Who is sponsoring clinical trial NCT02324036?
This trial is sponsored by University of California, Irvine, which has 368 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.